EGFR and breast carcinoma: Here we aim to specifically elucidate the route of internalisation of the EGFR during chemotactic invasion of the highly migratory breast cancer cell line MDA-MB-231 and test specific hypotheses mechanistically linking endocytosis to chemotactic invasion.